Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00018-009-0210-4.

Title:
Platelets in defense against bacterial pathogens | Cellular and Molecular Life Sciences
Description:
Platelets interact with bacterial pathogens through a wide array of cellular and molecular mechanisms. The consequences of this interaction may significantly influence the balance between infection and immunity. On the one hand, recent data indicate that certain bacteria may be capable of exploiting these interactions to gain a virulence advantage. Indeed, certain bacterial pathogens appear to have evolved specific ways in which to subvert activated platelets. Hence, it is conceivable that some bacterial pathogens exploit platelet responses. On the other hand, platelets are now known to possess unambiguous structures and functions of host defense effector cells. Recent discoveries emphasize critical features enabling such functions, including expression of toll-like receptors that detect hallmark signals of bacterial infection, an array of microbicidal peptides, as well as other host defense molecules and functions. These concepts are consistent with increased risk and severity of bacterial infection as correlates of clinical abnormalities in platelet quantity and quality. In these respects, the molecular and cellular roles of platelets in host defense against bacterial pathogens are explored with attention on advances in platelet immunobiology.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Law & Government

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

platelets, platelet, google, scholar, pubmed, cas, article, host, antimicrobial, defense, aureus, infection, human, pathogens, kinocidins, bacterial, pmps, infect, interactions, endocarditis, activation, aggregation, cells, studies, yeaman, protein, response, proteins, vitro, expression, immun, mechanisms, staphylococcus, molecular, role, factor, blood, including, microbicidal, bayer, responses, molecules, release, surface, demonstrated, clin, bacteria, receptor, activity, interact,

Topics {✒️}

n-formyl-methionyl-leucyl-phenylalanine n-f-met-leu-phe integrin glycoprotein iib/iiia f-met-leu-phe c-terminal deletion products article download pdf serine-aspartate-repeat protein serine-rich repeat domains multi-color flow cytometry tumor necrosis factor-α cd40-receptor-bearing cells platelet-mediated cytotoxicity induced local lipopolysaccharide-induced toxicity pneumococcus-induced serotonin release p2y12 receptor-induced amplification cognate anti-pneumococcal antibody lps-mediated cgmp upregulation possess cxc-chemokine motifs require pre-existing abnormalities connective tissue-activating peptide-3 high-affinity p2y12 inhibitor immune cell-cd40 ligand heat-stable bactericidal property serine-rich surface protein exou-induced vascular hyperpermeability fibrin-platelet matrix formed adenosine nucleotide-mediated activation develop anti-infective peptides platelet-derived growth factor fibrinogen-binding protein present heat-stable bactericidal capacity fowler vg jr excessive α-toxin leads cd40/ligand–cd40 interactions [9] radioisotope-labeled platelet studies platelet-derived microparticle detection harbor-ucla medical center delivering anti-infective molecules platelet-bacterial interaction proceeds nf-kappab pathways leading platelet tlr4-mediated responses lps-induced platelet aggregation activated platelet–fibrin clots staphylococcus aureus-derived proteinases malaria-infected erythrocytes binding platelet-binding protein gspb soluble cell-adhesion molecule recognizes platelet gc1qr/p33 aureus-induced platelet aggregation immunoglobulin-mediated immune responses

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Platelets in defense against bacterial pathogens
         description:Platelets interact with bacterial pathogens through a wide array of cellular and molecular mechanisms. The consequences of this interaction may significantly influence the balance between infection and immunity. On the one hand, recent data indicate that certain bacteria may be capable of exploiting these interactions to gain a virulence advantage. Indeed, certain bacterial pathogens appear to have evolved specific ways in which to subvert activated platelets. Hence, it is conceivable that some bacterial pathogens exploit platelet responses. On the other hand, platelets are now known to possess unambiguous structures and functions of host defense effector cells. Recent discoveries emphasize critical features enabling such functions, including expression of toll-like receptors that detect hallmark signals of bacterial infection, an array of microbicidal peptides, as well as other host defense molecules and functions. These concepts are consistent with increased risk and severity of bacterial infection as correlates of clinical abnormalities in platelet quantity and quality. In these respects, the molecular and cellular roles of platelets in host defense against bacterial pathogens are explored with attention on advances in platelet immunobiology.
         datePublished:2009-12-15T00:00:00Z
         dateModified:2009-12-15T00:00:00Z
         pageStart:525
         pageEnd:544
         license:https://creativecommons.org/licenses/by-nc/2.0
         sameAs:https://doi.org/10.1007/s00018-009-0210-4
         keywords:
            Platelets
            Host defenses
            Bacteria
            Pathogen
            Interactions
            Cell Biology
            Biomedicine
            general
            Life Sciences
            Biochemistry
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-009-0210-4/MediaObjects/18_2009_210_Fig1_HTML.gif
         isPartOf:
            name:Cellular and Molecular Life Sciences
            issn:
               1420-9071
               1420-682X
            volumeNumber:67
            type:
               Periodical
               PublicationVolume
         publisher:
            name:SP Birkhäuser Verlag Basel
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Michael R. Yeaman
               affiliation:
                     name:David Geffen School of Medicine at UCLA
                     address:
                        name:Division of Infectious Diseases, St. John’s Cardiovascular Research Center, Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Platelets in defense against bacterial pathogens
      description:Platelets interact with bacterial pathogens through a wide array of cellular and molecular mechanisms. The consequences of this interaction may significantly influence the balance between infection and immunity. On the one hand, recent data indicate that certain bacteria may be capable of exploiting these interactions to gain a virulence advantage. Indeed, certain bacterial pathogens appear to have evolved specific ways in which to subvert activated platelets. Hence, it is conceivable that some bacterial pathogens exploit platelet responses. On the other hand, platelets are now known to possess unambiguous structures and functions of host defense effector cells. Recent discoveries emphasize critical features enabling such functions, including expression of toll-like receptors that detect hallmark signals of bacterial infection, an array of microbicidal peptides, as well as other host defense molecules and functions. These concepts are consistent with increased risk and severity of bacterial infection as correlates of clinical abnormalities in platelet quantity and quality. In these respects, the molecular and cellular roles of platelets in host defense against bacterial pathogens are explored with attention on advances in platelet immunobiology.
      datePublished:2009-12-15T00:00:00Z
      dateModified:2009-12-15T00:00:00Z
      pageStart:525
      pageEnd:544
      license:https://creativecommons.org/licenses/by-nc/2.0
      sameAs:https://doi.org/10.1007/s00018-009-0210-4
      keywords:
         Platelets
         Host defenses
         Bacteria
         Pathogen
         Interactions
         Cell Biology
         Biomedicine
         general
         Life Sciences
         Biochemistry
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-009-0210-4/MediaObjects/18_2009_210_Fig1_HTML.gif
      isPartOf:
         name:Cellular and Molecular Life Sciences
         issn:
            1420-9071
            1420-682X
         volumeNumber:67
         type:
            Periodical
            PublicationVolume
      publisher:
         name:SP Birkhäuser Verlag Basel
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Michael R. Yeaman
            affiliation:
                  name:David Geffen School of Medicine at UCLA
                  address:
                     name:Division of Infectious Diseases, St. John’s Cardiovascular Research Center, Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cellular and Molecular Life Sciences
      issn:
         1420-9071
         1420-682X
      volumeNumber:67
Organization:
      name:SP Birkhäuser Verlag Basel
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:David Geffen School of Medicine at UCLA
      address:
         name:Division of Infectious Diseases, St. John’s Cardiovascular Research Center, Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Michael R. Yeaman
      affiliation:
            name:David Geffen School of Medicine at UCLA
            address:
               name:Division of Infectious Diseases, St. John’s Cardiovascular Research Center, Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Division of Infectious Diseases, St. John’s Cardiovascular Research Center, Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, USA

External Links {🔗}(471)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Isotope
  • Prism.js

CDN Services {📦}

  • Crossref

5.74s.